If you’re researching wrinkle remedies, you’ve in all probability come throughout the phrases Jeuveau toxin and Jeuveau Botox. While Jeuveau is commonly in comparison with Botox, there’s nonetheless plenty of confusion surrounding what it's, the way it works, and whether or not it’s protected.
Let’s set the file straight. Using information from scientific research, we’re busting the most important myths about Jeuveau so you may make knowledgeable, assured choices about your skin.
Myth 1: Jeuveau Toxin Is Completely Different From Botox
The Reality: Jeuveau and Botox both use botulinum toxin type A, a purified protein that relaxes facial muscle tissues to clean wrinkles. The distinction? Jeuveau was created particularly for beauty use. That’s proper, not an off-label medical remedy, simply magnificence.
Myth 2: “Jeuveau Botox” Is Just a Trendy Name
The Reality: While “Jeuveau Botox” is a standard search time period, Jeuveau is its personal FDA-approved product. It’s not only a rebrand to draw youthful shoppers; it's one thing completely different. In reality, it’s generally known as “Newtox” as a result of it provides a contemporary different to Botox with comparable efficiency and decrease price.
Myth 3: Jeuveau Doesn’t Last As Long As Botox
The Reality: In scientific trials, Jeuveau lasted 3 to 4 months, which is similar as Botox. In some research utilizing the next dose (40 models), Jeuveau even lasted as much as 6 months, with no further unwanted effects.
Myth 4: Jeuveau Toxin Works Slower Than Other Injectables
The Reality: Jeuveau may very well work quicker than Botox. Results are sometimes seen inside 2 to three days, whereas Botox sometimes takes 3 to 4. In head-to-head trials, Jeuveau ranked among the fastest for the onset of effect compared to other neuromodulators.
Myth 5: Jeuveau Isn’t as Safe
The Reality: Jeuveau was examined on 1000's of sufferers in U.S. and international trials and confirmed a really low fee of unwanted effects, much like Botox. Common points like delicate complications or bruising had been uncommon and short-term.
Myth 6: You Need More Jeuveau to Get Results
The Reality: Although Jeuveau is inexpensive than Botox, it makes use of the identical dosing models as Botox to get comparable results. It’s no more diluted, and no additional product is required for outcomes. They truly tout a classy purification approach that makes you much less more likely to have long-term unwanted effects.
Myth 7: Jeuveau Toxin Is Only for Women
The Reality: Jeuveau is protected and efficient for all genders and skin varieties. In reality, extra males are turning to wrinkle-relaxing remedies as a part of preventative skincare. Clinical trials included a various group of customers throughout age ranges, and the entire outcomes had been promising and corresponding to Botox.
Final Take: The Truth About Jeuveau Toxin and Jeuveau Botox
Don’t let outdated data or web rumors idiot you, Jeuveau toxin is a scientifically-backed, FDA-approved wrinkle remedy that holds its personal in opposition to Botox. It works quick, lasts lengthy, and should even prevent cash with out compromising on security or outcomes.
So whether or not you name it Jeuveau Botox, Jeuveau toxin, or “Newtox,” one factor is obvious: it’s not a fable. It’s a contemporary choice for smoother skin backed by actual science.
References
Beer, Okay.R., Shamban, A.T., Avelar, R.L., Gross, J.E., & Jonker, A. (2019). Efficacy and safety of prabotulinumtoxinA for the treatment of glabellar lines in adult subjects: results from 2 identical phase III studies. Dermatologic Surgery, 45(12), 1381-1393. DOI: 10.1097/DSS.0000000000001903
Cheon, H.I., Jung, N., Won, C.H., Kim, B.J., & Lee, Y.W. (2019). Efficacy and safety of prabotulinumtoxin A and onabotulinumtoxin A for crow’s feet: a phase 3, multicenter, randomized, double-blind, split-face study. Dermatologic Surgery, 45(12), 1610-1619. DOI: 10.1097/DSS.0000000000001920
Rzany, B.J., Ascher, B., Avelar, R.L., et al. (2020). A multicenter, randomized, double-blind, placebo-controlled, single-dose, phase 3, non-inferiority study comparing prabotulinumtoxinA and onabotulinumtoxinA for the treatment of moderate to severe glabellar lines in adult patients. Aesthetic Surgery Journal, 40(4), 413-429. DOI: 10.1093/asj/sjz110
Gadarowski, M.B., Ghamrawi, R., Taylor, S.L., & Feldman, S.R. (2021). PrabotulinumtoxinA-xvfs for the treatment of moderate-to-severe glabellar lines: a review of phase II and III clinical trials. Annals of Pharmacotherapy, 55(3), 279-287. DOI: 10.1177/1060028020943527
Avelar, R.L. (2024). Post hoc analysis comparing the safety and efficacy of prabotulinumtoxinA in millennials and nonmillennials with moderate to severe glabellar lines. Dermatologic Surgery, 50(9 Suppl), S42–S47. DOI: 10.1097/DSS.0000000000004249
Lemdani, M.S., Honig, S.E., Habarth-Morales, T.E., et al. (2025). Comparison of botulinum toxin A formulations for glabellar strain treatment in women: a double-blind randomized clinical trial. JAMA Dermatology, 161(7), 723-730. DOI: 10.1001/jamadermatol.2025.1335
Jung, B.Okay., Park, H., Cheon, Y.W., et al. (2023). Clinical investigation of botulinum toxin (prabotulinumtoxin A) for bruxism related to masseter muscle hypertrophy: a prospective study. Journal of Cranio-Maxillofacial Surgery, 51(5), 332-337. DOI: 10.1016/j.jcms.2023.05.005
Fagien, S., Avelar, R.L., Cox, S.E., Joseph, J.H., Kaufman-Janette, J., & Marcus, Okay.A. (2024). Safety and duration of effect of 40-unit prabotulinumtoxinA-xvfs for the treatment of moderate to severe glabellar lines in adult patients: a phase II, multicenter, randomized, double-blind, active-controlled trial. Aesthetic Surgery Journal, 44(9), 987-1000. DOI: 10.1093/asj/sjae051
Clifton, M. (2023). PrabotulinumtoxinA-xvfs (Jeuveau, Evolus) for the temporary treatment of glabellar lines: what does this toxin bring to the table? The Dermatology Digest.
European Medicines Agency. (2019). Nuceiva (botulinum toxin sort A) – EPAR Product Information. EMA/249428/2019. (Available at EMA web site).